United Health Products Update: Progress on FDA and Market Applications
United Health Products, Inc. (OTCPK: UEEC), located in Mt. Laurel, NJ, recently shared important news about its regulatory efforts and capital market activities.
The company revealed that the FDA requested additional sterilization and biotoxicity tests for its Investigational Device Exemption (IDE) application. This is a necessary step before United Health can begin enrolling patients in its clinical study, which involves 27 participants. Fortunately, the company received positive results from these tests, confirming that its CelluSTAT Hemostatic Gauze meets safety standards for Class III absorbable medical devices. These results have been submitted to the FDA as part of the revised IDE application.
In another development, United Health is also seeking to list its common shares on the OTCQB market. The OTC Markets requested more information about this application, and the company has since provided the necessary data to facilitate the review.
However, it’s important to note that there is no guarantee that the FDA will approve the premarket application or that the uplisting to the OTCQB will be granted.
About United Health Products
United Health Products has developed CelluSTAT Hemostatic Gauze, a natural product aimed at controlling mild to moderate bleeding. The company is actively pursuing approval to enter the human surgical market.
This situation comes at a time when the healthcare industry is evolving, with innovations in medical devices becoming crucial for effective treatments. As of recent data, the hemostatic agent market is expected to grow significantly, driven by the rising need for efficient bleeding control measures in surgical settings. According to a report by Market Research Future, the global hemostatic agent market is projected to reach $3 billion by 2025, growing at a compound annual growth rate (CAGR) of 8.1%.
For those interested in learning more about United Health Products, you can visit their official website at www.uhpcorp.com.
While there are still challenges ahead for United Health, the positive test results and ongoing reviews signal a step forward in their mission to provide innovative solutions for medical needs.
Check out this related article: Join 47 Million Health Workers and Advocates in the Fight for Cleaner Aid to Combat Pollution-Related Deaths
Source linkUHP, United Health Products, OTCQB, IDE application, FDA
